IS6223A - Fjölbrigða salt - Google Patents

Fjölbrigða salt

Info

Publication number: IS6223A
Authority: IS; Iceland
Prior art keywords: polymeric salt; polymeric; salt
Prior art date: 1999-09-28

Application number

IS6223A

Other languages

English (en)

Other versions

IS2162B (is

Inventor

Bentley Arthur

Arnold Howard-Field Simon

James Ogilvie Ronald

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-28

Filing date

2002-01-08

Publication date

2002-01-08

2002-01-08 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

2002-01-08 Publication of IS6223A publication Critical patent/IS6223A/is

2006-11-15 Publication of IS2162B publication Critical patent/IS2162B/is

Links

150000003839 salts Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Otolaryngology (AREA)
Obesity (AREA)
Pulmonology (AREA)
Hematology (AREA)
Diabetes (AREA)
Child & Adolescent Psychology (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Addiction (AREA)
Cardiology (AREA)
Anesthesiology (AREA)
Nutrition Science (AREA)
Hospice & Palliative Care (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)
Steroid Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IS6223A 1999-09-28 2002-01-08 Fjölbrigðasalt af lyfi gegn mígreni IS2162B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9922963.5A GB9922963D0 (en)	1999-09-28	1999-09-28	Polymorphic salt
PCT/IB2000/001305 WO2001023377A2 (en)	1999-09-28	2000-09-14	Polymorphic salt

Publications (2)

Publication Number	Publication Date
IS6223A true IS6223A (is)	2002-01-08
IS2162B IS2162B (is)	2006-11-15

Family

ID=10861767

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6223A IS2162B (is)	1999-09-28	2002-01-08	Fjölbrigðasalt af lyfi gegn mígreni

Country Status (50)

Country	Link
US (1)	US6369094B1 (is)
EP (1)	EP1233960B1 (is)
JP (1)	JP3795395B2 (is)
KR (1)	KR100479897B1 (is)
CN (1)	CN1155594C (is)
AP (1)	AP2004A (is)
AR (1)	AR025779A1 (is)
AT (1)	ATE246185T1 (is)
AU (1)	AU779580B2 (is)
BG (1)	BG65161B1 (is)
BR (1)	BR0014272A (is)
CA (1)	CA2379572C (is)
CO (1)	CO5180567A1 (is)
CR (1)	CR6561A (is)
CU (1)	CU23200A3 (is)
CZ (1)	CZ2002971A3 (is)
DE (1)	DE60004262T2 (is)
DK (1)	DK1233960T3 (is)
DZ (1)	DZ3254A1 (is)
EA (1)	EA004510B1 (is)
EE (1)	EE200200171A (is)
EG (1)	EG24143A (is)
ES (1)	ES2200911T3 (is)
GB (1)	GB9922963D0 (is)
GE (1)	GEP20043365B (is)
GT (1)	GT200000159A (is)
HK (1)	HK1048628B (is)
HR (1)	HRP20020270B1 (is)
HU (1)	HUP0202821A3 (is)
IL (1)	IL147154A (is)
IS (1)	IS2162B (is)
MA (1)	MA26821A1 (is)
MX (1)	MXPA02003311A (is)
MY (1)	MY121170A (is)
NO (1)	NO321936B1 (is)
NZ (1)	NZ516093A (is)
OA (1)	OA12024A (is)
PA (1)	PA8498901A1 (is)
PE (1)	PE20010662A1 (is)
PL (1)	PL354960A1 (is)
PT (1)	PT1233960E (is)
SI (1)	SI1233960T1 (is)
SK (1)	SK3982002A3 (is)
TN (1)	TNSN00187A1 (is)
TR (1)	TR200200804T2 (is)
TW (1)	TWI265926B (is)
UA (1)	UA72272C2 (is)
WO (1)	WO2001023377A2 (is)
YU (1)	YU2602A (is)
ZA (1)	ZA200202406B (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060025387A1 (en) *	1998-12-23	2006-02-02	Cytoscan Sciences Llc	Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
US8008283B2 (en) *	1998-12-23	2011-08-30	Neurotherapeutics Pharma, Inc.	Methods and compositions for the treatment of neuropsychiatric disorders
US8722668B2 (en) *	1998-12-23	2014-05-13	Daryl W. Hochman	Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US7214711B2 (en) *	1998-12-23	2007-05-08	Neurotherapeutics Pharma Llc	Method of treating migraine headache without aura
GB0018968D0 (en) *	2000-08-02	2000-09-20	Pfizer Ltd	Particulate composition
US7132549B2 (en)	2003-05-30	2006-11-07	Pfizer Inc.	Process
GB0312478D0 (en) *	2003-05-30	2003-07-09	Pfizer Ltd	Improved process
TR201907729T4 (tr) *	2004-12-03	2019-06-21	Merck Sharp & Dohme	Bir anti-çekirdekleştirici ajan içeren farmasötik bileşim.
JP2009511629A (ja) *	2005-10-17	2009-03-19	ニューロセラピューティクスファーマ，インコーポレイテッド	中枢神経系疾患の調節に有用な利尿薬様化合物類似体
KR100814109B1 (ko) *	2006-01-09	2008-03-14	한국생명공학연구원	로다닌 유도체, 이의 제조방법 및 이를 유효성분으로함유하는 약학적 조성물
TWI394753B (zh)	2006-03-17	2013-05-01	Otsuka Pharma Co Ltd	新穎替妥牟拉（ｔｅｔｏｍｉｌａｓｔ）晶體
WO2010116386A2 (en) *	2009-04-08	2010-10-14	Biophore India Pharmaceuticals Pvt. Ltd.	Novel polymorph of eletriptan hydrobromide and process for the preparation thereof
ES2898348T3 (es)	2009-10-26	2022-03-07	Merck Sharp & Dohme	Composiciones farmacéuticas sólidas que contienen un inhibidor de la integrasa

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5578612A (en)	1990-10-15	1996-11-26	Pfizer Inc.	Indole derivatives
US5559129A (en)	1990-10-15	1996-09-24	Pfizer Inc	Indole derivatives
US5607951A (en)	1990-10-15	1997-03-04	Pfizer Inc	Indole derivatives
US5559246A (en)	1990-10-15	1996-09-24	Pfizer Inc.	Indole derivatives
US5545644A (en)	1990-10-15	1996-08-13	Pfizer Inc.	Indole derivatives
CA2091562C (en) *	1990-10-15	2001-03-27	John Eugene Macor	Indole derivatives useful in psychotherapeutics
GB9417310D0 (en) *	1994-08-27	1994-10-19	Pfizer Ltd	Therapeutic agents
US5998462A (en) *	1996-12-16	1999-12-07	Allelix Biopharmaceuticals Inc.	5-alkyl indole compounds
SK284462B6 (sk) *	1997-07-03	2005-04-01	Pfizer Inc.	Vodná farmaceutická kompozícia obsahujúca eletriptan hemisulfát a jej použitie

1999
- 1999-09-28 GB GBGB9922963.5A patent/GB9922963D0/en not_active Ceased
2000
- 2000-07-25 TW TW089114850A patent/TWI265926B/zh not_active IP Right Cessation
- 2000-07-28 PA PA20008498901A patent/PA8498901A1/es unknown
- 2000-08-10 CO CO00059853A patent/CO5180567A1/es not_active Application Discontinuation
- 2000-09-14 EE EEP200200171A patent/EE200200171A/xx unknown
- 2000-09-14 NZ NZ516093A patent/NZ516093A/xx unknown
- 2000-09-14 PL PL00354960A patent/PL354960A1/xx not_active IP Right Cessation
- 2000-09-14 UA UA2002032432A patent/UA72272C2/uk unknown
- 2000-09-14 WO PCT/IB2000/001305 patent/WO2001023377A2/en not_active Ceased
- 2000-09-14 OA OA1200200077A patent/OA12024A/en unknown
- 2000-09-14 SI SI200030165T patent/SI1233960T1/xx unknown
- 2000-09-14 CZ CZ2002971A patent/CZ2002971A3/cs unknown
- 2000-09-14 CN CNB00810798XA patent/CN1155594C/zh not_active Expired - Fee Related
- 2000-09-14 SK SK398-2002A patent/SK3982002A3/sk unknown
- 2000-09-14 IL IL14715400A patent/IL147154A/xx not_active IP Right Cessation
- 2000-09-14 TR TR2002/00804T patent/TR200200804T2/xx unknown
- 2000-09-14 YU YU2602A patent/YU2602A/sh unknown
- 2000-09-14 AU AU67213/00A patent/AU779580B2/en not_active Ceased
- 2000-09-14 HU HU0202821A patent/HUP0202821A3/hu unknown
- 2000-09-14 EA EA200200302A patent/EA004510B1/ru not_active IP Right Cessation
- 2000-09-14 PT PT00954864T patent/PT1233960E/pt unknown
- 2000-09-14 CA CA002379572A patent/CA2379572C/en not_active Expired - Fee Related
- 2000-09-14 HK HK03100144.2A patent/HK1048628B/zh not_active IP Right Cessation
- 2000-09-14 DK DK00954864T patent/DK1233960T3/da active
- 2000-09-14 DZ DZ003254A patent/DZ3254A1/fr active
- 2000-09-14 KR KR10-2002-7003963A patent/KR100479897B1/ko not_active Expired - Fee Related
- 2000-09-14 DE DE60004262T patent/DE60004262T2/de not_active Expired - Lifetime
- 2000-09-14 EP EP00954864A patent/EP1233960B1/en not_active Expired - Lifetime
- 2000-09-14 AT AT00954864T patent/ATE246185T1/de not_active IP Right Cessation
- 2000-09-14 MX MXPA02003311A patent/MXPA02003311A/es active IP Right Grant
- 2000-09-14 JP JP2001526529A patent/JP3795395B2/ja not_active Expired - Fee Related
- 2000-09-14 GE GE4699A patent/GEP20043365B/en unknown
- 2000-09-14 BR BR0014272-7A patent/BR0014272A/pt not_active Application Discontinuation
- 2000-09-14 ES ES00954864T patent/ES2200911T3/es not_active Expired - Lifetime
- 2000-09-14 AP APAP/P/2002/002457A patent/AP2004A/en active
- 2000-09-14 HR HR20020270A patent/HRP20020270B1/xx not_active IP Right Cessation
- 2000-09-19 US US09/664,946 patent/US6369094B1/en not_active Expired - Fee Related
- 2000-09-25 EG EG20001216A patent/EG24143A/xx active
- 2000-09-26 MY MYPI20004476A patent/MY121170A/en unknown
- 2000-09-26 AR ARP000105032A patent/AR025779A1/es active IP Right Grant
- 2000-09-26 GT GT200000159A patent/GT200000159A/es unknown
- 2000-09-26 PE PE2000001010A patent/PE20010662A1/es not_active Application Discontinuation
- 2000-09-27 TN TNTNSN00187A patent/TNSN00187A1/fr unknown
2001
- 2001-12-10 CU CU20010293A patent/CU23200A3/es not_active IP Right Cessation
- 2001-12-19 BG BG106240A patent/BG65161B1/bg unknown
2002
- 2002-01-08 IS IS6223A patent/IS2162B/is unknown
- 2002-01-24 CR CR6561A patent/CR6561A/es not_active Application Discontinuation
- 2002-03-15 MA MA26556A patent/MA26821A1/fr unknown
- 2002-03-26 ZA ZA200202406A patent/ZA200202406B/en unknown
- 2002-03-26 NO NO20021525A patent/NO321936B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
PL354960A1 (en)	2004-03-22
NZ516093A (en)	2005-01-28
HUP0202821A3 (en)	2003-12-29
HRP20020270B1 (en)	2004-04-30
TR200200804T2 (tr)	2002-07-22
CA2379572A1 (en)	2001-04-05
GB9922963D0 (en)	1999-12-01
BG106240A (en)	2002-07-31
HUP0202821A2 (hu)	2003-01-28
EP1233960A2 (en)	2002-08-28
CZ2002971A3 (cs)	2003-04-16
HRP20020270A2 (en)	2003-06-30
OA12024A (en)	2006-04-19
WO2001023377A3 (en)	2002-03-07
NO20021525D0 (no)	2002-03-26
WO2001023377A2 (en)	2001-04-05
SI1233960T1 (en)	2003-12-31
KR20020032627A (ko)	2002-05-03
TNSN00187A1 (fr)	2005-11-10
MY121170A (en)	2005-12-30
DE60004262T2 (de)	2004-01-22
ES2200911T3 (es)	2004-03-16
JP2003510318A (ja)	2003-03-18
AP2004A (en)	2009-06-10
CR6561A (es)	2005-04-04
ZA200202406B (en)	2003-05-28
NO321936B1 (no)	2006-07-24
CU23200A3 (es)	2007-04-06
HK1048628A1 (en)	2003-04-11
IL147154A (en)	2005-11-20
JP3795395B2 (ja)	2006-07-12
CO5180567A1 (es)	2002-07-30
UA72272C2 (uk)	2005-02-15
CA2379572C (en)	2006-11-14
ATE246185T1 (de)	2003-08-15
DK1233960T3 (da)	2003-10-27
EA200200302A1 (ru)	2002-10-31
KR100479897B1 (ko)	2005-03-31
NO20021525L (no)	2002-03-26
MXPA02003311A (es)	2002-10-04
DZ3254A1 (fr)	2001-04-05
IL147154A0 (en)	2002-08-14
PE20010662A1 (es)	2001-06-23
PA8498901A1 (es)	2004-02-07
YU2602A (sh)	2004-11-25
HK1048628B (zh)	2004-10-21
US6369094B1 (en)	2002-04-09
EA004510B1 (ru)	2004-04-29
IS2162B (is)	2006-11-15
MA26821A1 (fr)	2004-12-20
AU6721300A (en)	2001-04-30
AU779580B2 (en)	2005-01-27
AP2002002457A0 (en)	2002-06-30
CN1155594C (zh)	2004-06-30
TWI265926B (en)	2006-11-11
EP1233960B1 (en)	2003-07-30
EG24143A (en)	2008-08-06
GEP20043365B (en)	2004-05-10
EE200200171A (et)	2003-06-16
SK3982002A3 (en)	2003-05-02
GT200000159A (es)	2002-03-20
BG65161B1 (bg)	2007-04-30
AR025779A1 (es)	2002-12-11
CN1364166A (zh)	2002-08-14
DE60004262D1 (de)	2003-09-04
WO2001023377A9 (en)	2002-03-28
PT1233960E (pt)	2003-11-28
BR0014272A (pt)	2002-05-21

Publication	Publication Date	Title
DE60036160D1 (de)	2007-10-11	Elektroentionisierungsvorrichtung
DE60011764D1 (de)	2004-07-29	Werkstoffsprüfung
DE69932949D1 (de)	2006-10-05	Aufszugssteuerung
DE60002808D1 (de)	2003-06-26	Propellerrotornabe
PT1218009E (pt)	2005-05-31	Grandulos de quetiapina
DK1244625T3 (da)	2005-10-10	4-pyridinyl-n-acyl-l-phenylalaniner
DK1190020T3 (da)	2006-03-20	Celluligninbrændstof
DE50009570D1 (de)	2005-03-31	Wechselcorrugator
DE60001894T2 (de)	2004-01-29	Busschienenverbindungsstruktur
PT1218096E (pt)	2004-08-31	Microcapsulas de libertacao variavel
DE69924240D1 (de)	2005-04-21	Ladungsträgerteilchenstrahlvorrichtung
PT1163256E (pt)	2004-07-30	Hemi-hidrato de 16-alfa-bromoepiandrosterona
PT1233960E (pt)	2003-11-28	Sal polimorfico
DE60025623D1 (de)	2006-04-06	Bohrmeisselverbinder
PT1235566E (pt)	2005-08-31	Formulacao injectavel de valnemulina
DE50012482D1 (de)	2006-05-18	Tibiamarknagel
DE60013238D1 (de)	2004-09-30	Klingenabstreifanordnung
DE60020201D1 (de)	2005-06-23	Koaxialkabelherstellungsverfahren
DE50003660D1 (de)	2003-10-16	Diacylhydrazinderivate
DE60027753D1 (de)	2006-06-08	Kompositnadel
DE19983890T1 (de)	2002-03-07	Ventiltaktgebungsjustiereinrichtung
DE69926805D1 (de)	2005-09-22	Formblaszusammensetzung
DE60000485D1 (de)	2002-10-31	Kulturgefass
DK1242386T3 (da)	2009-12-14	Nitro-sulfobenzamider
DE60037169D1 (de)	2008-01-03	Chrominanzsignalinterpolation